Published in Radiother Oncol on March 01, 1991
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.52
Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 3.67
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol (1991) 3.36
Complete sequence of the bithorax complex of Drosophila. Proc Natl Acad Sci U S A (1995) 2.29
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst (1996) 2.19
Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys (1982) 2.05
Why the utility of a normalized dose-response gradient (gamma-factor) should be redefined. Int J Radiat Oncol Biol Phys (1998) 2.04
Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science (1991) 2.01
Influence of preirradiation of lung on development of artificial pulmonary metastases of fibrosarcoma in mice. Cancer Res (1973) 1.96
Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin. Infect Immun (1988) 1.75
Clinical implementation of dynamic intensity-modulated radiotherapy: Dosimetric aspects and initial experience. J Med Phys (2008) 1.72
Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys (1995) 1.63
Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys (1989) 1.48
Alteration in myelin-associated proteins following spinal cord irradiation in guinea pigs. Int J Radiat Oncol Biol Phys (1992) 1.47
Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys (1989) 1.43
Delayed molecular responses to brain irradiation. Int J Radiat Biol (1997) 1.39
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res (1974) 1.39
Interfraction interval and dose-response in RTOG trials--regarding Fu et al., IJROBP 32:577-588; 1995. Int J Radiat Oncol Biol Phys (1995) 1.38
Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. Cancer Res (1978) 1.30
Saliva-mediated aggregation of Enterococcus faecalis transformed with a Streptococcus sanguis gene encoding the SSP-5 surface antigen. Infect Immun (1989) 1.29
Gradual regeneration of mouse testicular stem cells after exposure to ionizing radiation. Radiat Res (1978) 1.28
Radiation survival and regeneration characteristics of spermatogenic stem cells of mouse testis. Radiat Res (1974) 1.27
Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys (1983) 1.25
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol (1995) 1.24
A new isoeffect curve for change in dose per fraction. Radiother Oncol (1983) 1.23
Tumor and normal tissue response to metronidazole and irradiation in mice. Radiology (1974) 1.21
Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys (1995) 1.20
Radiosensitivity and fractionation response of crypt cells of mouse jejunum. Radiat Res (1969) 1.19
Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. Radiat Res (1989) 1.18
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) Int J Radiat Oncol Biol Phys (2000) 1.16
Serum complement levels in infancy: age related changes. Pediatr Res (1979) 1.14
Partial properdin deficiency. J Lab Clin Med (1980) 1.14
Salivary-agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria. Infect Immun (1991) 1.12
The dose-survival relationship for irradiation of epithelial cells of mouse skin. Br J Radiol (1967) 1.12
Recovery and repopulation in vivo by mouse skin epithelial cells during fractionated irradiation. Radiat Res (1967) 1.08
A gene family in Drosophila melanogaster coding for trypsin-like enzymes. Nucleic Acids Res (1985) 1.08
Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer (1985) 1.06
Radiation-induced astrocytic and microglial responses in mouse brain. Radiother Oncol (1993) 1.06
Radiosensitization of mouse spermatogenic stem cells by Ro-07-0582. Radiat Res (1977) 1.06
The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.06
Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor. Int J Radiat Oncol Biol Phys (1997) 1.06
Isolation from a murine fibrosarcoma of cell lines with enhanced plating efficiency in vitro. J Natl Cancer Inst (1978) 1.05
Cell cycle dependency of metastatic lung colony formation. Cancer Res (1977) 1.05
The effect of single doses of radiation on mouse spinal cord. Int J Radiat Oncol Biol Phys (1992) 1.05
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res (1995) 1.03
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res (1994) 1.02
Molecular pathways that modify tumor radiation response. Am J Clin Oncol (2001) 1.01
Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol (1990) 1.00
Transitional cell carcinoma in a urachal cyst. J Urol (1999) 1.00
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer Suppl (1984) 1.00
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol (1999) 0.99
Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation. Radiology (1979) 0.98
Optimization of dose distribution with multi-leaf collimator using field-in-field technique for parallel opposing tangential beams of breast cancers. J Med Phys (2008) 0.98
Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers. Ann Intern Med (1985) 0.98
Biologic basis for altered fractionation schemes. Cancer (1985) 0.97
Radiation response of clonogenic cell populations separated from fibrosarcoma. Radiat Res (1975) 0.96
The relationship of acute to late skin injury in 2 and 5 fraction/week gamma-ray therapy. Int J Radiat Oncol Biol Phys (1979) 0.96
The effects of bone on proton NMR relaxation times of surrounding liquids. Invest Radiol (1986) 0.95
Evaluation methods for detecting changes in beam output and energy in radiation beams from high-energy linear accelerators. J Med Phys (2007) 0.95
Gangliogliomas: experience with 34 patients and review of the literature. Am J Clin Oncol (1998) 0.94
First determination of the weak charge of the proton. Phys Rev Lett (2013) 0.94
Post-operative radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys (1978) 0.94
Wrist pain syndrome in the gymnast. Pathogenetic, diagnostic, and therapeutic considerations. Am J Sports Med (1989) 0.94
Metronidazole: effect on radiosensitivity of tumor and normal tissues in mice. J Natl Cancer Inst (1975) 0.94
Extrapolation chamber mounted on perspex for calibration of high energy photon and electron beams from a clinical linear accelerator. J Med Phys (2009) 0.94
Combination of taxanes with radiation: preclinical studies. Semin Radiat Oncol (1999) 0.93
Proliferative capability of parietal and zymogen cells. J Anat (1975) 0.93
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol (1995) 0.93
Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice. Cancer Res (1974) 0.92
Tumor radioresistance in clinical radiotherapy. Int J Radiat Oncol Biol Phys (1982) 0.92
Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. Cancer (1974) 0.92
Subcutaneous transposition of the ulnar nerve for treatment of cubital tunnel syndrome. Hand Clin (1996) 0.91
Letter: Enhancement of the radioresponse of a murine tumour by a nitroimidazone. Br J Radiol (1975) 0.91
Simple technique for fabrication of shielding blocks for total body irradiation at extended treatment distances. J Med Phys (2009) 0.90
Vertebral mineral determination by quantitative computed tomography (QCT): accuracy of single and dual energy measurements. J Comput Assist Tomogr (1988) 0.90
A method for estimation of accuracy of dose delivery with dynamic slit windows in medical linear accelerators. J Med Phys (2008) 0.90
Lipid/water ratio of bone marrow measured by phase-encoded proton nuclear magnetic resonance spectroscopy. Invest Radiol (1987) 0.89
The kinetics of recovery in irradiated colonic mucosa of the mouse. Cancer (1974) 0.89
Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum. Int J Cancer (1974) 0.89
The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncol (1997) 0.89
Use of focus groups to explore consumers' preferences for content and graphic design of nutrition publications. J Am Diet Assoc (1989) 0.89
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. Eur J Cancer (1997) 0.88
Need of patient-specific quality assurance and pre-treatment verification program for special plans in radiotherapy. J Med Phys (2011) 0.88
Test of equal effect per fraction and estimation of initial clonogen number in microcolony assays of survival after fractionated irradiation. Br J Radiol (1980) 0.88
Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys (1998) 0.88
Variability of DNA content of murine fibrosarcoma cells. Nature (1977) 0.88
A receptor-binding region in human choriogonadotropin/lutropin beta subunit. Proc Natl Acad Sci U S A (1987) 0.88
Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. Radiother Oncol (1986) 0.88
Assay of radiation effects in mouse skin as expressed in wound healing. Radiat Res (1988) 0.87
Dose-response relationship for elective neck irradiation of head and neck cancer--facts and controversies. Neoplasma (1998) 0.87
Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice. Int J Cancer (1975) 0.87
Dose-survival characteristics of epithelial cells of mouse intestinal mucosa. Radiology (1968) 0.87
A dose-surviving fraction curve for mouse colonic mucosa. Eur J Cancer Clin Oncol (1983) 0.87
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. Int J Cancer (1995) 0.87